🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/12/2015 | 159,15 | 162,50 | 158,17 | 160,91 | +0,63% | 2,72% | 129.200 |
| 23/12/2015 | 159,28 | 160,56 | 156,74 | 159,90 | +1,25% | 2,40% | 370.500 |
| 22/12/2015 | 158,42 | 159,18 | 154,37 | 157,93 | -0,14% | 3,04% | 480.700 |
| 21/12/2015 | 155,66 | 158,28 | 155,40 | 158,15 | +1,91% | 1,85% | 469.600 |
| 18/12/2015 | 159,13 | 162,06 | 155,18 | 155,18 | -1,87% | 4,32% | 840.000 |
| 17/12/2015 | 160,74 | 160,74 | 156,77 | 158,14 | -0,82% | 2,47% | 327.500 |
| 16/12/2015 | 160,96 | 164,04 | 156,52 | 159,45 | -0,33% | 4,67% | 372.500 |
| 15/12/2015 | 154,54 | 160,57 | 151,57 | 159,97 | +4,91% | 5,82% | 706.300 |
| 14/12/2015 | 153,30 | 155,58 | 150,28 | 152,49 | -0,44% | 3,46% | 437.100 |
| 11/12/2015 | 154,14 | 156,49 | 150,83 | 153,16 | -1,82% | 3,67% | 542.700 |
| 10/12/2015 | 153,39 | 156,56 | 152,71 | 156,00 | +1,51% | 2,51% | 628.600 |
| 09/12/2015 | 159,07 | 160,81 | 152,38 | 153,68 | -4,13% | 5,30% | 550.400 |
| 08/12/2015 | 154,19 | 160,52 | 153,94 | 160,30 | +3,09% | 4,27% | 487.500 |
| 07/12/2015 | 158,04 | 159,23 | 153,70 | 155,49 | -2,08% | 3,50% | 309.700 |
| 04/12/2015 | 157,19 | 160,30 | 155,46 | 158,80 | +2,29% | 3,08% | 406.300 |
| 03/12/2015 | 158,12 | 158,12 | 152,00 | 155,24 | -0,97% | 3,87% | 549.800 |
| 02/12/2015 | 158,81 | 159,55 | 155,81 | 156,76 | -1,41% | 2,36% | 433.500 |
| 01/12/2015 | 154,36 | 159,87 | 151,99 | 159,00 | +4,17% | 5,10% | 651.000 |
| 30/11/2015 | 154,26 | 156,72 | 151,18 | 152,63 | -1,06% | 3,59% | 551.000 |
| 27/11/2015 | 155,60 | 156,96 | 152,46 | 154,26 | -0,80% | 2,89% | 150.900 |
| 25/11/2015 | 154,11 | 156,73 | 153,34 | 155,51 | +0,83% | 2,20% | 627.900 |
| 24/11/2015 | 152,00 | 155,16 | 149,74 | 154,23 | +0,84% | 3,57% | 508.000 |
| 23/11/2015 | 151,52 | 156,05 | 150,57 | 152,95 | +1,18% | 3,62% | 354.600 |
| 20/11/2015 | 149,04 | 152,90 | 149,04 | 151,17 | +1,57% | 2,59% | 344.300 |
| 19/11/2015 | 152,04 | 152,74 | 146,93 | 148,84 | -1,79% | 3,82% | 369.500 |
| 18/11/2015 | 149,55 | 151,79 | 146,24 | 151,55 | +2,38% | 3,71% | 528.700 |
| 17/11/2015 | 146,41 | 150,44 | 145,62 | 148,02 | +1,39% | 3,29% | 348.900 |
| 16/11/2015 | 145,88 | 147,23 | 142,52 | 145,99 | -0,54% | 3,23% | 316.500 |
| 13/11/2015 | 146,34 | 148,60 | 144,47 | 146,79 | +0,44% | 2,82% | 399.200 |
| 12/11/2015 | 147,66 | 149,50 | 141,69 | 146,14 | -1,70% | 5,29% | 579.300 |